glp 1 agonist saxenda Saxenda© – A New Treatment for Obesity GLP-1 Agonists for Weight Loss:

Consistent with these pathological findings, both semaglutide and tirzepatide significantly lowered liver triglycerides (TG) and total cholesterol (TC) (Fig.4-C, D)

6,7 Glucagon-like peptide-1 receptor agonists (GLP-1RAs), indicated for type 2 diabetes mellitus (T2DM) and weight loss, 7 have seen a 5-fold increase in their market share since 2020

There is also a more subtle risk worth knowing: the Pasqua 2025 trial reported two cases of euglycemic ketosis without acidosis in semaglutide-treated participants

The prevalence of obesity and T2DM are increasing both globally [9, 10] and in Sweden [11, 12]

Coupons disappear

Intriguingly, in patients with dumping syndrome, postprandial serum catecholamine rises correspond with increased serum GLP-1 levels (184)